Get started
MarketMoversReport

MediciNova Announces Positive Top-Line Results

Long
MediciNova, Inc. (NASDAQ:MNOV)  
MarketMoversReport  
NASDAQ:MNOV   MediciNova, Inc.
Beyond Technical Analysis
0
0
beyondta
MNOV: MediciNova, Inc.
2022-06-08 06:30:00
MediciNova Announces Positive Top-Line Results from Phase 2 Clinical Trial of MN-166 (ibudilast) in Hospitalized COVID-19 Patients at Risk for Acute Respiratory Distress Syndrome
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.